News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
186,761 Results
Type
Article (9773)
Company Profile (65)
Press Release (176923)
Section
Business (58538)
Career Advice (584)
Deals (10756)
Drug Delivery (23)
Drug Development (24784)
Employer Resources (39)
FDA (5009)
Job Trends (4741)
News (98163)
Policy (7337)
Tag
Academia (800)
Africa (203)
Alliances (16034)
Alzheimer's disease (294)
Antibody-drug conjugate (ADC) (18)
Approvals (4992)
Arizona (30)
Artificial intelligence (17)
Asia (10887)
Australia (2215)
Bankruptcy (34)
Best Places to Work (3992)
Biotechnology (51)
Breast cancer (18)
C2C Services and Suppliers (20015)
California (662)
Canada (283)
Cancer (157)
Career advice (504)
Cell therapy (46)
China (46)
Clinical research (19475)
Collaboration (53)
Colorado (34)
Connecticut (22)
COVID-19 (791)
Cystic fibrosis (25)
Data (110)
Diabetes (31)
Diagnostics (1991)
Drug pricing (21)
Earnings (22127)
Employer resources (32)
Europe (27643)
Events (24379)
Executive appointments (59)
FDA (5064)
Florida (72)
Funding (52)
Gene therapy (29)
Georgia (20)
GLP-1 (180)
Government (1175)
Healthcare (5592)
Hotbed/Location (128410)
Illinois (76)
Indiana (56)
Infectious disease (797)
Inflammatory bowel disease (29)
Interviews (115)
IPO (4779)
Job creations (804)
Job search strategy (429)
Kansas (34)
Layoffs (83)
Legal (1084)
Lung cancer (40)
Manufacturing (22)
Maryland (92)
Massachusetts (427)
Medical device (4195)
Medtech (4196)
Mergers & acquisitions (5995)
Metabolic disorders (79)
Michigan (26)
Minnesota (33)
Neuroscience (335)
New Hampshire (18)
New Jersey (141)
New York (178)
NextGen Class of 2024 (1935)
Non-profit (1083)
North Carolina (186)
Northern California (314)
Obesity (45)
Ohio (42)
Opinion (61)
Patents (24)
Pennsylvania (158)
People (15806)
Phase I (6659)
Phase II (8862)
Phase III (6021)
Pipeline (45)
Policy (21)
Postmarket research (548)
Preclinical (2501)
Rare diseases (39)
Real estate (1765)
Regulatory (5317)
Research institute (723)
Resumes & cover letters (68)
South America (316)
Southern California (260)
Startups (1277)
Texas (61)
United States (2503)
Vaccines (117)
Washington State (56)
Weight loss (37)
Date
Today (73)
Last 7 days (245)
Last 30 days (707)
Last 365 days (12640)
2024 (8660)
2023 (13251)
2022 (16692)
2021 (18204)
2020 (17287)
2019 (14062)
2018 (10809)
2017 (10306)
2016 (9186)
2015 (10732)
2014 (7344)
2013 (6157)
2012 (6859)
2011 (6962)
2010 (5758)
186,761 Results for "front range biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Lucid Diagnostics Signs Memorandum of Understanding with Front Line Mobile Health
September 3, 2024
·
4 min read
Deals
Coherus BioSciences Announces Divestiture of YUSIMRY (adalimumab-aqvh) in a $40 Million Upfront All Cash Transaction– Transaction aligns with Coherus’ strategic focus on oncology –
Coherus BioSciences, Inc today announced it agreed to divest YUSIMRY (adalimumab-aqvh) to Hong Kong King-Friend Industrial Co. Ltd. (HKF) for up-front all-cash consideration of $40 million.
June 27, 2024
·
4 min read
Compensation
Pay Range Transparency: New Law Could Help Massachusetts Biopharma Industry
Massachusetts’ new salary range transparency law can be a tool for companies looking to attract biopharma professionals while also helping candidates and current employees improve their job searches and salaries, according to two experts.
August 21, 2024
·
5 min read
·
Angela Gabriel
Deals
Wedgewood Pharmacy Acquires Front Range Laboratories, Addressing a Growing Need for Testing Compounded Medications for Animal Health
Wedgewood Pharmacy has acquired Front Range Laboratories in Loveland, CO, which is a full-service testing laboratory that has been a trusted partner of compounding pharmacies for more than 25 years.
February 27, 2023
·
2 min read
Drug Development
Mirati, Amgen, Lilly and More Race to the Front Line in KRAS-Mutated NSCLC
While Amgen and Mirati are widely viewed as frontrunners to win the first front line approval, analysts—and competitors—say the field is still wide open.
November 21, 2023
·
6 min read
·
Mollie Barnes
Drug Development
Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line MSS-CRC
Gritstone bio, Inc. announced positive preliminary data from the ongoing, signal seeking Phase 2 portion of the Phase 2/3 study evaluating GRANITE, its personalized neoantigen cancer vaccine, in front-line metastatic microsatellite stable colorectal cancer.
April 1, 2024
·
9 min read
Business
Industry Veteran and RNA Therapeutics Expert, John Maraganore, Joins Tevard Biosciences as Strategic Advisor and Board Observer
Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today announced the appointment of John Maraganore, Ph.D., as a Strategic Advisor and Board Observer.
June 24, 2024
·
1 min read
Genetown
Exsilio Therapeutics Launches with $82 Million Series A Financing to Develop Redosable Genomic Medicines for A Broad Range of Diseases
Exsilio Therapeutics, a biotechnology company developing genomic medicines for a broad range of diseases, announced its emergence from stealth with $82 million in Series A financing.
June 25, 2024
·
3 min read
Biotech Beach
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
Ensysce Biosciences, Inc. today announced the renewal of its collaboration with Quotient Sciences to undertake the study PF614-MPAR-102 to examine and evaluate the full commercial dose range of the PF614-MPAR drug product.
May 20, 2024
·
5 min read
Business
Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results
Range Impact, Inc. (OTC: RNGE) (“Range Impact”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reported its results for the fourth quarter and fiscal year ended December 31, 2023.
March 29, 2024
·
10 min read
1 of 18,677
Next
